Aligos Therapeutics, Inc. - Common stock (ALGS) analyst actions
Rating and price-target actions on ALGS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ALGS overview →
1 measured ALGS analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects | Press release | +3.85% | +1.10% |
Keep exploring
More ALGS: earnings → · SEC filings → · ALGS overview →